MIND diet to improve thinking and memory after breast cancer
The MIND-BC Study: MIND Diet for Breast Cancer Cognition
This trial will try the MIND diet with breast cancer survivors who finished adjuvant treatment 6 months to three years ago and report thinking or memory problems and a low MIND diet score to see if it helps compared with usual diet.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute Academic / other |
| Locations | 1 site (Tampa, Florida) |
| Trial ID | NCT07018986 on ClinicalTrials.gov |
What this trial studies
This is a randomized, controlled intervention at an academic cancer center comparing a structured MIND diet program to usual diet among stage I–III breast cancer survivors reporting cancer-related cognitive impairment and a low baseline MIND diet score. Eligible participants are adults who completed adjuvant treatment 6 months to three years earlier and are willing and able to follow the dietary program. The protocol includes two sequential 12-week phases: an intensive intervention phase followed by a maintenance phase. Primary outcomes focus on cognitive function and diet adherence measured over the intervention and maintenance periods.
Who should consider this trial
Good fit: Ideal candidates are English-speaking adults (age >18) with prior stage I–III breast cancer who completed adjuvant treatment 6 months to three years ago, report recent cognitive problems they attribute to cancer or its treatment, have a low MIND diet score, and are willing to follow the MIND diet.
Not a fit: Patients who already follow a healthy MIND-like diet, who have cognitive impairment from other neurological or psychiatric conditions, or who do not meet the post-treatment timing requirements are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, following the MIND diet could improve thinking, memory, and quality of life for breast cancer survivors with treatment-related cognitive complaints.
How similar studies have performed: Observational studies have linked the MIND diet to better brain health in older adults, but randomized trials testing the MIND diet specifically for cancer-related cognitive impairment are limited, so this approach is relatively novel in this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Previously diagnosed with stage I-III breast cancer. * Able to speak and read English. * Able to consume foods orally. * \>18 years of age. * Able to provide informed consent. * Have no documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., schizophrenia). * Report 'somewhat' to 'very much' cognitive impairment in the past week (i.e., a score ≥ 2 on a 0-4 scale) that they attribute to cancer or its treatment. * Report a MIND diet score \< 10 (range 0 to 14, higher score equates to higher diet quality). * Willing to consume the MIND diet. * Completed adjuvant treatment 6 months to three years previously. Exclusion Criteria: * Not meeting all of the inclusion criteria.
Where this trial is running
Tampa, Florida
- Moffitt Cancer Center — Tampa, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Sylvia Crowder — Moffitt Cancer Center
- Study coordinator: Crystal Bryant
- Email: Crystal.Bryant@moffitt.org
- Phone: 813-745-2168
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.